Clinical Trial

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Study acronym: IMGeS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the effectiveness and safety of mitomycin-c and gemcitabine sequential instillation in BCG unresponsive high risk non-muscle invasive bladder cancer patients.
Protocol Amendment History 1 change
minor Completion pushed: 2027-12-31 -> 2028-12-31 2026-05-30
Trial Details
NCT Number NCT06388720
Lead Sponsor National Cancer Center, Korea
Collaborators: Korea University Anam Hospital, Pusan National University Hospital, Samsung Medical Center, Severance Hospital, Seoul National University Bundang Hospital, Seoul St. Mary's Hospital, Chonnam National University Hospital
Conditions Bladder Cancer
Enrollment 82 participants
Start Date 2024-11-19
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29